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Background
A major impediment to addressing the epidemic of persis-
tent pain conditions is the development of classification
procedures that capture the mosaic of signs and symptoms
that accompany these disorders. According to the bio-psy-
cho-social model, the measurable features of an idiopathic
pain condition such as temporomandibular disorder
(TMD) are associated with abnormalities in sensory, psy-
chological, neuroimmune, and autonomic systems, which
arise due to the interaction of genetic and environmental
risk factors. Using a high-dimensional dataset derived
from a large TMD case-control study, we have developed
a new method to integrate clinically assessed intermediate
phenotypes across bio-psycho-social domains, clustering
subjects in a manner that provides clinically useful prog-
nostic and diagnostic information. We performed a candi-
date gene association study to identify genes that influence
cluster assignment in order to characterize the genetic
determination of these clusters.
Materials and methods
Cluster analysis was performed to identify subgroups
within the Orofacial Pain: Prospective Evaluation and Risk
Assessment (OPPERA) study, which included 1,031 TMD
cases and 3,247 controls. TMD status was confirmed
using the Research Diagnostic Criteria for TMD (RDC/
TMD); each participant was also assessed for psychological
characteristics, medical history, and sensitivity to experi-
mental pain. Supervised 3-means clustering was applied to
the pain sensitivity and psychological data using the 15
features most strongly associated with TMD. Subjects
were genotyped using a candidate gene panel of 2,924 sin-
gle nucleotide polymorphisms (SNPs) corresponding to
358 pain-relevant genes. We assessed association between
cluster identity and SNP genotypes using logistic
regression.
Results
In the contrast between Cluster 1 (n=1180, characterized
by low pain sensitivity and low psychological distress) and
Cluster 3 (n=273, high pain, high distress), the strongest
association was with the SNP rs2498982 (minor allele fre-
quency = 0.39), in the INADL gene (standardized
OR=1.57, p=1.1x10-5). This gene is a scaffolding protein
regulating tight junctions in sensory neurons, including
interactions between channels involved in nociception
such as ASIC3. No statistically significant (after Bonferroni
correction) associations were observed in the contrast of
Cluster 2 (n=1571, moderate pain, low distress) with Clus-
ter 3 although the strongest signal (p=4.4x10-4) was again
observed in INADL, indicating this gene may distinguish
individuals in Cluster 3, with the highest risk of TMD. We
also identified other genes potentially contributing to
molecular pathways affecting cluster assignment.
Conclusions
Using a novel clustering method to classify individuals into
diagnostic categories, we have identified a genetic variant
in INADL associated with the subgroup with the highest
risk for TMD.
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